Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Evosep Collaborate on High-Throughput Proteomic Workflows

NEW YORK – Liquid chromatography firm Evosep said on Tuesday that it is collaborating with Agilent Technologies on high-throughput workflows for clinical proteomics.

Odense, Denmark-based Evosep said the firms aim to develop robust methods capable of analyzing thousands of tissue and plasma proteomes.

"The Evosep One separation solution fits perfectly with the routine focused applications developed by Agilent Technologies by enabling really high-throughput sample separation for [mass spec] analyses while still being extremely easy to use for the customer," Nicolai Bache, head of application at Evosep, said in a statement.

Evosep has similar agreements with other mass spec vendors including Thermo Fisher Scientific and Bruker.

 

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.